Biopharmas in Asia-Pacific raising money in public or private financings, including: Allovir, Immuron, Selva.

Quarterly snapshots from biopharma companies with marketed products, including: Biogen.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Adaptvac, Altimmune, Amag, Ampio, Amyris, Arcturus, Astellas, Astrazeneca, Bavarian Nordic, Biocomo, Biofourmis, Biontech, Bostongene, Brainstorm Cell, Cel-Sci, Chugai, Clarity, Covaxx, Daiichi Sankyo, Dynavax, Emergent Biosolutions, Eqrx, Evotec, Fibrogenesis, Fujifilm, G1, Hansoh, Humanetics, Imaginab, Immuron, Inflarx, Irbm, Kaleido, Lynk, Medicinova, Medigen Vaccine, Memed, Merck, Mitsubishi, NEC, Norgine, Novavax, Noxopharm, Onconova, Oragenics, PDS, Pfizer, Smartpharm, Sorrento, Therapeutics Solutions, Valneva, Vigene.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Epimab, I-Mab, Mesoblast.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Neocis, Nowdiagnostics.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aegea Biotechnologies, Aminoverse, Bioivt, Ciox Health, Cytosorbents, Datos Health, Edifecs, Exagen, Guided Therapeutics, Heart Health Intelligence, Hims & Hers, Ireceptor Plus, Medal, Midwest Institute for Minimally Invasive Therapies, Neuroone Medical Technologies, Orbis Diagnostics, Osi Systems, Saykara, Tauriga Sciences, Truework, Tscan, Twist Bioscience, Vaica Medical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ibex, Ortho Regenerative Technologies.

Med-tech firms raising money in public or private financings, including: Bioaffinity Technologies, Nano-X Imaging, Nemaura Medical, Sequana Medical.

New hires and promotions in the med-tech industry, including: Clinical Genomics, Covera Health, Experion Holdings, Meridian Bioscience, Mimedx Group, Phreesia, Sensus Healthcare, Tecan Group, Varex Imaging.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Apogenix, Black Diamond, Chi-Med, Foresee, Hemoshear, Larimar, Momenta, Nabriva, Protara, Realta.